Original Article

You have full text access to this OnlineOpen article

The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma

Potential for decreased toxicity and combination with biologic therapy

  1. Roy S. Herbst M.D., Ph.D.1,†,*,
  2. Fadlo R. Khuri M.D.1,
  3. Charles Lu M.D.1,
  4. Diane D. Liu M.S.2,
  5. Frank V. Fossella M.D.1,
  6. Bonnie S. Glisson M.D.1,
  7. Katherine M. W. Pisters M.D.1,
  8. Dong M. Shin M.D.3,
  9. Vassiliki A. Papadimitrakopoulou M.D.1,
  10. Jonathan M. Kurie M.D.1,
  11. George Blumenschein Jr. M.D.1,
  12. Merrill S. Kies M.D.1,
  13. Ralph Zinner M.D.1,
  14. Maria S. Jung B.S.N.4,
  15. Robert Lu B.S.N.1,
  16. J. Jack Lee M.D.2,
  17. Reginald F. Munden M.D.5,
  18. Waun Ki Hong M.D.1,
  19. Jin Soo Lee M.D.1

Article first published online: 11 JUL 2002

DOI: 10.1002/cncr.10629

Issue

Cancer

Cancer

Volume 95, Issue 2, pages 340–353, 15 July 2002

Additional Information

How to Cite

Herbst, R. S., Khuri, F. R., Lu, C., Liu, D. D., Fossella, F. V., Glisson, B. S., Pisters, K. M. W., Shin, D. M., Papadimitrakopoulou, V. A., Kurie, J. M., Blumenschein, G., Kies, M. S., Zinner, R., Jung, M. S., Lu, R., Lee, J. J., Munden, R. F., Hong, W. K. and Lee, J. S. (2002), The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma. Cancer, 95: 340–353. doi: 10.1002/cncr.10629

Author Information

  1. 1

    Department of Thoracic/Head & Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

  2. 2

    Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

  3. 3

    University of Pittsburgh, Pittsburgh, Pennsylvania

  4. 4

    Department of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

  5. 5

    Department of Diagnostic Radiology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

  1. †

    Fax: (713) 796-8655

*The University of Texas M.D. Anderson Cancer Center, Box 432, 1515 Holcombe Boulevard; Houston, Texas 77030-4009

Publication History

  1. Issue published online: 11 JUL 2002
  2. Article first published online: 11 JUL 2002
  3. Manuscript Accepted: 19 FEB 2002
  4. Manuscript Revised: 9 JAN 2002
  5. Manuscript Received: 13 NOV 2001

Funded by

  • Eli Lilly and Company
  • American Society of Clinical Oncology (ASCO) Career Development Award

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (545K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hiroshi Hashimoto, Yoshinori Nakagishi, Kiyohaya Obara, Yoshiro Oshika, A Patient with Advanced Lung Adenocarcinoma Effectively Treated with Gemcitabine Plus Vinorelbine After Failure with Gefitinib, Haigan, 2010, 50, 3, 297

    CrossRef

  2. 2
    Chitta Ranjan Patra, Resham Bhattacharya, Debabrata Mukhopadhyay, Priyabrata Mukherjee, Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer, Advanced Drug Delivery Reviews, 2010, 62, 3, 346

    CrossRef

  3. 3
    Satoshi Oizumi, Koichi Yamazaki, Hiroshi Yokouchi, Jun Konishi, Fumihiro Hommura, Tetsuya Kojima, Hiroshi Isobe, Masaharu Nishimura, Phase I study of amrubicin and vinorelbine in non-small cell lung cancer previously treated with platinum-based chemotherapy, International Journal of Clinical Oncology, 2009, 14, 2, 125

    CrossRef

  4. 4
    H. TADA, S. MATSUI, M. KAWAHARA, S. HOSOE, C. HAMADA, M. FUKUSHIMA, Efficacy, toxicity and cost analysis for non-platinum triplet (gemcitabine and vinorelbine, followed by docetaxel) vs. platinum-based chemotherapy in IIIB/IV non-small-cell lung cancer: single-institution experience, European Journal of Cancer Care, 2008, 17, 2
    Direct Link:
  5. 5
    Dae Ho Lee, Ji-Youn Han, Heung Tae Kim, Sung Jin Yoon, Hong Ryull Pyo, Kwan Ho Cho, Sang-Hoon Shin, Heon Yoo, Seung-Hoon Lee, Jin Soo Lee, Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first, Cancer, 2008, 113, 1
    Direct Link:
  6. 6
    Dae Ho Lee, Ji-Youn Han, Seong Min Yoon, Jae Jin Lee, Hong Gi Lee, Hyae Young Kim, Sung Jin Yoon, Eun Kyung Hong, Jin Soo Lee, A Pilot Trial of Gemcitabine and Vinorelbine Plus Capecitabine in Locally Advanced or Metastatic Nonsmall Cell Lung Cancer, American Journal of Clinical Oncology, 2006, 29, 2, 143

    CrossRef

  7. 7
    Rosalyn Juergens, Julie Brahmer, David Ettinger, Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter, Cancer Chemotherapy and Pharmacology, 2006, 59, 5, 621

    CrossRef

  8. 8
    Takayasu Kurata, Keitaro Matsuo, Minoru Takada, Masaaki Kawahara, Masahiro Tsuji, Yuka Matsubara, Nagahiro Otani, Shigeki Matsuyama, Kenya Muraishi, Tetsuya Fujita, Masato Ishikawa, Keita Koyano, Isamu Okamoto, Taroh Satoh, Kenji Tamura, Kazuhiko Nakagawa, Masahiro Fukuoka, Is the Importance of Achieving Stable Disease Different between Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Cytotoxic Agents in the Second-Line Setting for Advanced Non-small Cell Lung Cancer?, Journal of Thoracic Oncology, 2006, 1, 7, 684

    CrossRef

  9. 9
    V. Westeel, J.L. Breton, D. Braun, E. Quoix, B. Milleron, D. Debieuvre, P. Jacoulet, C. Germa, L. Kayitalire, A. Depierre, Long-duration, weekly treatment with gemcitabine plus vinorelbine for non-small cell lung cancer: A multicenter phase II study, Lung Cancer, 2006, 51, 3, 347

    CrossRef

  10. 10
    Fabrice Barlési, Patrick Villani, Christophe Doddoli, Céline Gimenez, Jean-Pierre Kleisbauer, Gemcitabine-induced severe pulmonary toxicity, Fundamental & Clinical Pharmacology, 2004, 18, 1
    Direct Link:
  11. 11
    Mei Zhang, Michael Boyer, Laurent Rivory, Angela Hong, Stephen Clarke, Graham Stevens, Kate Fife, Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non–small-cell lung cancer cells, International Journal of Radiation Oncology*Biology*Physics, 2004, 58, 2, 353

    CrossRef

  12. 12
    Tony S. K. Mok, Anthony T. C. Chan, Nonplatinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer, Clinical Pulmonary Medicine, 2003, 10, 3, 143

    CrossRef

  13. 13
    Giuseppe Giaccone, Egbert Smit, Cancer Chemotherapy and Biological Response Modifiers Annual Volume 21, 2003,

    CrossRef

View Full Article (HTML) Get PDF (545K)